HFS
HRMY icon

Hantz Financial Services’s Harmony Biosciences HRMY Stock Holding History

Hantz Financial Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Buy
1,056
+402
+61% +$12.7K ﹤0.01% 1756
2026
Q1 		$18K Sell
654
-63
-9% -$2.07K ﹤0.01% 1897
2025
Q4 		$27K Sell
717
-145
-17% -$4.77K ﹤0.01% 1663
2025
Q3 		$24K Buy
862
+466
+118% +$16.1K ﹤0.01% 1499
2025
Q2 		$13K Buy
+396
New +$12.7K ﹤0.01% 1428

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hantz Financial Services's HRMY Position: Q2 2026 in Review

Hantz Financial Services increased its Harmony Biosciences (HRMY) stake by 61% in Q2 2026, buying an estimated $12.7K and bringing the position to 1,056 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Hantz Financial Services first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Hantz Financial Services held 1,056 shares of Harmony Biosciences worth $38K as of Q2 2026.
  • Hantz Financial Services bought 402 Harmony Biosciences shares in Q2 2026, an estimated $12.7K.
  • Harmony Biosciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1756 holding.
  • Hantz Financial Services first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.